The Lancet Oncology: For new HPV DNA test, study finds there may be little benefit in screening women aged 55 with a negative test

(The Lancet) Regular cytology screening (pap or smear test) is still the most commonly used HPV screening method, and can prevent cancers up to age 75 years, although benefits decline with age.For the newly introduced HPV DNA test, which offers a higher degree of accuracy, women aged 55 who have a negative test were predicted to be at low risk of cervical cancer.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news